ResMed Will Report Fiscal First Quarter Earnings October 29
San Diego-based ResMed will detail its latest financial performance for investors and industry stakeholders.
Updated on Oct. 1, 2026 in Public Companies
Live Poll
Do you generally trust public earnings reports to accurately reflect a company's future performance?
ResMed is scheduled to report its financial results for the first quarter of fiscal year 2027 after the close of the New York Stock Exchange on October 29, 2026. Management will host an investor webcast to discuss the company's financial and operational performance.
Why it matters
The earnings release provides a critical look at the operational health and product adoption rates of the San Diego-headquartered medical device manufacturer. Investors and industry peers monitor these results to gauge market demand across the 140 countries where ResMed products are currently deployed.
ResMed serves patients and providers across 140 countries, with performance trends now set to be revealed in the upcoming quarterly filing. The specific figures for the first quarter of fiscal year 2027 are currently pending disclosure.
The players
ResMed
A San Diego-based medical technology company that develops cloud-connectable medical devices for treating sleep apnea, COPD, and other chronic diseases.
The details
ResMed will move away from traditional phone-based live access for its earnings call, requiring participants to utilize the company's dedicated investor relations website to view the webcast. A replay will be made available approximately two hours after the conclusion of the event. For those unable to access the online platform, a phone-based replay will remain accessible for a limited window using conference ID 13762822.
Timeline
The live earnings webcast begins at 1:30 p.m. PT on October 29, 2026.
The webcast replay becomes available after 3:30 p.m. PT on October 29, 2026.
Phone replay access concludes on November 12, 2026.
Market Landscape
The upcoming report follows the company's established pattern for the 2026 fiscal year-end reporting cycle. The timing aligns with standard industry practices for public companies listed on both the New York Stock Exchange and the Australian Securities Exchange.
Operators should watch the upcoming report for indicators regarding product demand and supply chain efficiency across ResMed's global footprint. Review the disclosures on October 29 to adjust your own business strategy if you are a supplier or competitor in the medical device sector.
The takeaway
The transition to a digital-only live event format signals a continued push by ResMed to consolidate investor interactions through their proprietary web portal. Monitor the company's investor relations site on October 29 to analyze the reported revenue and margin metrics for the new fiscal year.
What happens next
A replay of the earnings webcast will be available for approximately two weeks following the October 29, 2026, live event, with the phone-based access ending on November 12, 2026.
Further reading
For more updates on regional corporate developments, visit the Public Companies section.
More information
To access the financial results and management discussion, visit the Resmed investor relations and earnings webcast.
Live Poll
Do you generally trust public earnings reports to accurately reflect a company's future performance?
